Tolterodine Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablets/ Capsules(IR & ER)
Available Strengths: IR: 1 mg, 2 mg; ER: 2mg, 4 mg
Reference Brands: Detrol, Detrol LA(US & EU)
Category:
Urology
Tolterodine capsules and tablets are antimuscarinic agents that block bladder muscarinic receptors, reducing involuntary contractions. They alleviate symptoms of overactive bladder, including urgency, frequency, and incontinence. Benefits include improved bladder control, enhanced daily comfort, and increased quality of life for patients suffering from bladder overactivity.
Tolterodine Tablets is available in Tablets/ Capsules(IR & ER)
and strengths such as IR: 1 mg, 2 mg; ER: 2mg, 4 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Tolterodine Tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Tolterodine Tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Tolterodine capsules and tablets, marketed as Detrol and Detrol LA, are approved in the US by the FDA and in the EU via EMA for overactive bladder treatment. Regulatory approval requires a comprehensive dossier including clinical efficacy, safety, manufacturing quality, and pharmacovigilance plans. In the US, the FDA reviews clinical trial and manufacturing data, while the EMA ensures compliance with regional standards.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing